Immunogenicity of the 9-Valent HPV Vaccine Using 2-Dose Regimens in Girls and Boys vs a 3-Dose Regimen in Women

---

Atıf İçin Kopyala

Iversen O., Miranda M. J., Ulied A., Soerdal T., Lazarus E., Chokephaibulkit K., ...Daha Fazla

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, cilt.316, sa.22, ss.2411-2421, 2016 (SCI-Expanded)

• Yayın Türü: Makale / Tam Makale
• Cilt numarası: 316 Sayı: 22
• Basım Tarihi: 2016
• Doi Numarası: 10.1001/jama.2016.17615
• Dergi Adı: JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
• Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
• Sayfa Sayıları: ss.2411-2421
• Hacettepe Üniversitesi Adresli: Evet

Özet

IMPORTANCE Human papillomavirus (HPV) infections cause anogenital cancers and warts. The 9-valent HPV vaccine provides protection against 7 high-risk types of HPV responsible for 90% of cervical cancers and 2 other HPV types accounting for 90% of genital warts.